CDT Equity Inc. (formerly Conduit Pharmaceuticals Inc.) is a clinical-stage specialty biopharmaceutical company based in Naples, Florida. The company adopted a cryptocurrency treasury reserve strategy in September 2025, purchasing BTC with existing cash reserves.
| Instrument | Term | Coupon | Principal | Outstanding | Conv. price | BTC Rating |
|---|---|---|---|---|---|---|
| CDT-AGP | Nov '24 – Dec '99 | 0% | 5.70M USD | 5.50M USD | — | 0.6x |
| CDT-Jul26 | Mar '26 – Jul '26 | 10% | 555.56K USD | 555.56K USD | — | >10x |
| Total | 6.06M USD | |||||
Post 1:25 reverse split effective Mar 26, 2026; ~4,722,450 post-split shares
Form 8-K (1-for-25 reverse stock split)Adjusted for 1:25 split Mar 2026 (pre-adjustment: 4,420,963)
DEF 14A (Special Meeting March 2026)Partial conversion of $200K on Oct 28, 2025
Form 10-Q (Q3 2025)